News|Articles|September 29, 2021

In the Lab eNewsletter

  • Pharmaceutical Technology's In the Lab eNewsletter, October 2021
  • Volume 16
  • Issue 10

USP Publishes General Chapter 1220 of Analytical Procedure Life Cycle

USP is publishing the analytics-focused chapter, which considers validation activities, in advance of the official publication.

The United States Pharmacopeia announced on Sept, 24, 2021, that it is publishing the approved General Chapter <1220> “Analytical Procedure Life Cycle”. The new chapter considers the validation activities that occur throughout the life cycle of an analytical procedure.

This chapter is being published in advance of the official publication posting to allow stakeholders additional time for reading and understanding the new chapter. It will be incorporated into USP–NF 2022, Issue 1 on Nov. 1, 2021 and will become official on May 1, 2022.

The chapter can be accessed here. Questions may be directed to Horacio Pappa, senior director of General Chapters, at hp@usp.org.

Source: USP-NF


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.